Geneoscopy closes $105 M in Series C funding round to power next-generation of gastrointestinal diagnostic tests

Geneoscopy, Inc., a life sciences company focused on developing diagnostic tests for the advancement of gastrointestinal health, today announced the closing of a Series C funding round raising $105 million.

Study finds aspirin reduces colon cancer risk, with benefits varying by lifestyle factors

Aspirin can reduce colorectal cancer risk, but its effectiveness varies based on lifestyle factors such as diet, BMI, and smoking. Personalized recommendations are crucial to

August 7, 2024

Do yellow fever vaccines truly provide effective lifelong protection against the disease after a single dose?

The long-term protection offered by one dose of vaccine against yellow fever.

January 25, 2024

Survey reveals alarming dental decay rates in Kentucky preschoolers

The University of Kentucky College of Dentistry’s 2023 Kentucky Early Learners’ Oral Health Surveillance Project survey found dental decay rates for Kentucky children ages 2

November 8, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.